Tumor Biology

期刊全称Tumor Biology
期刊缩写Tumor Biol.
涉及主题
(科研通AI识别)
生物医学遗传学内科学化学生物化学癌症癌症研究基因病理免疫学肿瘤科细胞生物学细胞凋亡细胞细胞培养外科
期刊介绍

Tumor Biology is a peer reviewed, international journal providing an open access forum for experimental and clinical cancer research. Tumor Biology covers all aspects of tumor markers, molecular biomarkers, tumor targeting, and mechanisms of tumor development and progression. Specific topics of interest include, but are not limited to: Pathway analyses, Non-coding RNAs, Circulating tumor cells, Liquid biopsies, Exosomes, Epigenetics, Cancer stem cells, Tumor immunology and immunotherapy, Tumor microenvironment, Targeted therapies, Therapy resistance Cancer genetics, Cancer risk screening. Studies in other areas of basic, clinical and translational cancer research are also considered in order to promote connections and discoveries across different disciplines. The journal publishes original articles, reviews, commentaries and guidelines on tumor marker use. All submissions are subject to rigorous peer review and are selected on the basis of whether the research is sound and deserves publication. Tumor Biology is the Official Journal of the International Society of Oncology and BioMarkers (ISOBM).

期刊ISSNprint: 1010-4283
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
00000003.65
历年发表/被引量
(科研通AI通过大数据分析)
年份20252024202320222021202020192018201720162015201420132012
发表量293320364111237070880916801410863429
被引量492410983134171596918556200701871518705193861517411462658136262304
h-Index70
自引率N.A.
涉及的研究领域医学-肿瘤学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
期刊主页https://www.springer.com/journal/13277https://us.sagepub.com/en-us/nam/tumor-biology/journal202707
投稿网址https://www.editorialmanager.com/TUBI
出版商Springer Netherlands
出版国家(地区)SWITZERLAND
出版语言English
出版周期Bimonthly
每年出版文章数1625
Gold OA文章占比0.00%
原创研究文献占比
(排除综述)
0.00%
SCI收录类型

Scopus (CiteScore)

Directory of Open Access Journals (DOAJ)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1010-4283%5BISSN%5D
平均审稿周期平均1.0个月
平均录用比例约27.5%
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈